Regulatory Considerations in the Development of Radiation-Drug Combinations

This article reviews the existing regulatory framework in which cancer drugs may be developed for use in combination with radiation therapy from the perspective of the US Food and Drug Administration (FDA).
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research